Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients.
Harb
Tareq S
TS
Cardiology Unit, Department of Medicine, University of Rochester Medical Center, New York 14642, USA.
Zareba
Wojciech
W
Moss
Arthur J
AJ
Ridker
Paul M
PM
Rifai
Nader
N
Marder
Victor J
VJ
Miller-Watelet
Luc
L
D001053:Apolipoproteins / Q000097:blood; D015415:Biomarkers / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications*; D007249:Inflammation / Q000097:blood / Q000150:complications*; D008055:Lipids / Q000097:blood; D016015:Logistic Models; D008297:Male; D009203:Myocardial Infarction / Q000097:blood* / Q000150:complications; D000685:Serum Amyloid A Protein; D013927:Thrombosis / Q000097:blood / Q000150:complications*
D001053:Apolipoproteins; D015415:Biomarkers; D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D008055:Lipids; D000685:Serum Amyloid A Protein; C036309:fibrin fragment D; D002097:C-Reactive Protein